We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current CSTL market cap is 626.96M. The company's latest EPS is USD -2.0935 and P/E is -10.94.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 55M | 38.64M | 42.04M | 50.14M | 61.49M |
Operating Income | -3.7M | -22.83M | -31.52M | -21.16M | -9.64M |
Net Income | -20.25M | -20.62M | -29.2M | -18.78M | -6.91M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 51.87M | 64.53M | 94.09M | 155.33M | 219.79M |
Operating Income | 7.33M | -6.54M | -40.08M | -72.86M | -67.98M |
Net Income | 2.99M | -10.28M | -31.29M | -67.14M | -57.47M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 457.81M | 447.33M | 426.89M | 425.4M | 436.02M |
Total Liabilities | 46.38M | 48.18M | 41.74M | 46.63M | 50.24M |
Total Equity | 411.43M | 399.15M | 385.15M | 378.77M | 385.78M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 119.75M | 439.33M | 462.57M | 447.33M | 453.34M |
Total Liabilities | 34.63M | 23.64M | 50.83M | 48.18M | 62.07M |
Total Equity | 85.11M | 415.69M | 411.74M | 399.15M | 391.27M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -35.66M | -41.66M | -25.44M | -29.23M | -24.21M |
Investing | -162.06M | -166.55M | 16.58M | 1.2M | -8.51M |
Financing | 2.27M | 1.52M | 728k | 954k | 999k |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 7.02M | 9.87M | -18.98M | -41.66M | -5.63M |
Investing | -937k | -4.75M | -66.66M | -166.55M | -16.18M |
Financing | 88.29M | 305.89M | 5.42M | 1.52M | -2.3M |
Market Cap | 626.96M |
Price to Earnings Ratio | -10.94 |
Price to Sales Ratio | 2.86 |
Price to Cash Ratio | 6.36 |
Price to Book Ratio | 1.61 |
Dividend Yield | - |
Shares Outstanding | 27.45M |
Average Volume (1 week) | 217.74k |
Average Volume (1 Month) | 150.34k |
52 Week Change | 1.47% |
52 Week High | 26.70 |
52 Week Low | 9.2601 |
Spread (Intraday) | 1 (4.17%) |
Company Name | Castle Biosciences Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.castlebiosciences.com |
Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions